We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.18B
AUM Growth
-$112M
Cap. Flow
-$159M
Cap. Flow %
-13.49%
Top 10 Hldgs %
34.43%
Holding
372
New
125
Increased
6
Reduced
44
Closed
64

Top Buys

Rank Stock Value
1
MBC icon
MasterBrand
MBC
+$33.6M
2
NE icon
Noble Corp
NE
+$30.1M
3
COF icon
Capital One
COF
+$17.7M
4
LEN.B icon
Lennar Class B
LEN.B
+$15.2M
5
APLS
Apellis Pharmaceuticals
APLS
+$9.28M

Sector Composition

Rank Sector Weight
1 Financials 33.32%
2 Healthcare 19.05%
3 Consumer Discretionary 8.98%
4 Energy 6.58%
5 Materials 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IOVA icon
51
Iovance Biotherapeutics
IOVA
$1.93B
$6.39M 0.54%
1,000,000
-705,000
-41% -$5.5M
MATV icon
52
Mativ Holdings
MATV
$507M
$6.27M 0.53%
+300,000
New +$6.5M
PRVB
53
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$5.81M 0.49%
+550,000
New +$4.44M
KG
54
Kestrel Group
KG
$66.7M
$5.33M 0.45%
126,321
-93,679
-43% -$3.99M
TRAQ
55
DELISTED
Trine II Acquisition Corp.
TRAQ
$5.15M 0.44%
499,300
TECK icon
56
Teck Resources
TECK
$31.8B
$5.11M 0.43%
+135,000
New +$4.67M
BHAC
57
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
$5.03M 0.43%
500,000
-1,420,775
-74% -$14.3M
CVNA icon
58
Carvana
CVNA
$74.8B
$4.87M 0.41%
5,135,500
-3,114,500
-38% -$6.58M
NUVB icon
59
Nuvation Bio
NUVB
$2.14B
$4.8M 0.41%
2,500,000
-80,000
-3% -$162K
NKGN
60
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
$4.79M 0.41%
481,190
CCTS
61
DELISTED
Cactus Acquisition Corp. 1 Limited Class A Ordinary Share
CCTS
$4.62M 0.39%
450,000
PNST
62
DELISTED
Pinstripes Holdings, Inc.
PNST
$4.59M 0.39%
450,000
LKFT
63
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.75B
$4.52M 0.38%
101,771
-21,000
-17% -$884K
IVVD icon
64
Invivyd
IVVD
$163M
$4.5M 0.38%
3,000,000
-390,000
-12% -$1.08M
INSW icon
65
International Seaways
INSW
$4.71B
$4.44M 0.38%
120,000
-40,000
-25% -$1.62M
VCSA
66
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$4.41M 0.37%
175,000
-17,082
-9% -$796K
APMI
67
DELISTED
AxonPrime Infrastructure Acquisition Corporation Class A Common Stock
APMI
$4.37M 0.37%
441,137
RXO icon
68
RXO
RXO
$3.42B
$4.3M 0.36%
+250,000
New +$4.43M
C icon
69
Citigroup
C
$230B
$4.3M 0.36%
+95,000
New +$4.32M
GXO icon
70
PUT
GXO Logistics
GXO
$6.03B
$4.27M 0.36%
+100,000
New +$4.01M
LIVB
71
DELISTED
LIV Capital Acquisition Corp. II Class A Ordinary Shares
LIVB
$4.16M 0.35%
405,000
GMFI
72
DELISTED
Aetherium Acquisition Corp
GMFI
$4.05M 0.34%
398,200
EIGR
73
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$3.68M 0.31%
103,833
-40,492
-28% -$4.86M
MU icon
74
CALL
Micron Technology
MU
$1.01T
$3.62M 0.31%
+72,500
New +$3.97M
RRAC
75
DELISTED
Rigel Resource Acquisition Corp.
RRAC
$3.6M 0.3%
350,000

Similar funds

683 Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, 683 Capital Management held 372 positions worth $1.18B, down 8.7% from $1.29B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

683 Capital Management withdrew a net $159M in Q4 2022, closing 64 positions and reducing 44 holdings. Its most notable exit was Lennar Class A, an estimated $41.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, 683 Capital Management opened a new position in MasterBrand worth $31M.

  • 683 Capital Management's largest Q4 2022 buy was MasterBrand: 4,100,000 shares worth $31M.
  • 683 Capital Management added most to Capital One in Q4 2022, an estimated $17.7M increase.
  • 683 Capital Management's biggest Q4 2022 reduction was Enova International, cutting an estimated $22.8M.
  • 683 Capital Management fully exited Lennar Class A in Q4 2022, selling an estimated $41.7M.
  • 683 Capital Management's ten largest holdings make up 34% of its $1.18B portfolio in Q4 2022.
  • 683 Capital Management opened 125 new positions and closed 64 in Q4 2022.
  • 683 Capital Management's portfolio value fell 8.7% quarter-over-quarter to $1.18B.

Based on 683 Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.